Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
•
Cornea and External Disease
How do you decide on treatment modality for ocular surface squamous neoplasia?
Related Questions
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
How do you approach the management of a patient with a small, indeterminate choroidal mass with no obvious primary malignancy?
When should amblyopia treatment be initiated in patients being treated for retinoblastoma?
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
In which settings would you use external beam radiotherapy for retinoblastoma in the upfront (new diagnosis) setting?
When do you consider performing laser refractive surgery on corneal transplants?
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
In patients with sicca symptoms and positive SSA/SSB how often do you perform other diagnostic testing such as salivary gland ultrasound, biopsy, Shirmers, ocular staining, stimulated salivary flow, etc?
What is your approach for LINAC based radiosurgery when dealing with benign perioptic lesions very close to the optics apparatus?
What factors influence your decision to pursue surgical management in cases of infectious keratitis caused by multidrug-resistant pathogens?
